+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cancer Therapies - Market Analysis, Trends, and Forecasts

  • ID: 834980
  • Report
  • 264 Pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Amgen
  • Astrazeneca Plc
  • Bayer Ag
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Johnson & Johnson
  • MORE
The Cancer Therapies market worldwide is projected to grow by US$93.1 Billion, driven by a compounded growth of 7.9%. Chemotherapy, one of the segments analyzed and sized in this study, displays the potential to grow at over 8.6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$74.8 Billion by the year 2025, Chemotherapy will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 6.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$3.2 Billion to the region's size and clout in the next 5 to 6 years. Over US$2.8 Billion worth of projected demand in the region will come from the rest of the European markets. In Japan, Chemotherapy will reach a market size of US$3.6 Billion by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 11.8% over the next couple of years and add approximately US$26.1 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • Amgen, Inc.
  • AstraZeneca plc
  • Bayer AG
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer, Inc.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Amgen
  • Astrazeneca Plc
  • Bayer Ag
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Johnson & Johnson
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Cancer Therapies Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Cancer Therapies Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Cancer Therapies Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Cancer Therapies Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Chemotherapy (Treatment Type) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Chemotherapy (Treatment Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Chemotherapy (Treatment Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Targeted Therapy (Treatment Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Targeted Therapy (Treatment Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Targeted Therapy (Treatment Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: Immunotherapy (Treatment Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 11: Immunotherapy (Treatment Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 12: Immunotherapy (Treatment Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Hormonal Therapy (Treatment Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025

TABLE 14: Hormonal Therapy (Treatment Type) Market Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 15: Hormonal Therapy (Treatment Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 16: Other Treatment Types (Treatment Type) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 17: Other Treatment Types (Treatment Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 18: Other Treatment Types (Treatment Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 19: Blood Cancer (Cancer Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025

TABLE 20: Blood Cancer (Cancer Type) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 21: Blood Cancer (Cancer Type) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

TABLE 22: Breast Cancer (Cancer Type) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025

TABLE 23: Breast Cancer (Cancer Type) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017

TABLE 24: Breast Cancer (Cancer Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 25: Prostate Cancer (Cancer Type) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 26: Prostate Cancer (Cancer Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 27: Prostate Cancer (Cancer Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 28: Gastrointestinal Cancer (Cancer Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 29: Gastrointestinal Cancer (Cancer Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 30: Gastrointestinal Cancer (Cancer Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 31: Gynecologic Cancer (Cancer Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 32: Gynecologic Cancer (Cancer Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 33: Gynecologic Cancer (Cancer Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 34: Respiratory/Lung Cancer (Cancer Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025

TABLE 35: Respiratory/Lung Cancer (Cancer Type) Market Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 36: Respiratory/Lung Cancer (Cancer Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 37: Other Cancer Types (Cancer Type) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 38: Other Cancer Types (Cancer Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 39: Other Cancer Types (Cancer Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Cancer Therapies Market Share (in %) by Company: 2019 & 2025

TABLE 40: United States Cancer Therapies Market Estimates and Projections in US$ Million by Treatment Type: 2018 to 2025

TABLE 41: Cancer Therapies Market in the United States by Treatment Type: A Historic Review in US$ Million for 2009-2017

TABLE 42: United States Cancer Therapies Market Share Breakdown by Treatment Type: 2009 VS 2019 VS 2025

TABLE 43: United States Cancer Therapies Market Estimates and Projections in US$ Million by Cancer Type: 2018 to 2025

TABLE 44: Cancer Therapies Market in the United States by Cancer Type: A Historic Review in US$ Million for 2009-2017

TABLE 45: United States Cancer Therapies Market Share Breakdown by Cancer Type: 2009 VS 2019 VS 2025

CANADA

TABLE 46: Canadian Cancer Therapies Market Estimates and Forecasts in US$ Million by Treatment Type: 2018 to 2025

TABLE 47: Canadian Cancer Therapies Historic Market Review by Treatment Type in US$ Million: 2009-2017

TABLE 48: Cancer Therapies Market in Canada: Percentage Share Breakdown of Sales by Treatment Type for 2009, 2019, and 2025

TABLE 49: Canadian Cancer Therapies Market Estimates and Forecasts in US$ Million by Cancer Type: 2018 to 2025

TABLE 50: Canadian Cancer Therapies Historic Market Review by Cancer Type in US$ Million: 2009-2017

TABLE 51: Cancer Therapies Market in Canada: Percentage Share Breakdown of Sales by Cancer Type for 2009, 2019, and 2025

JAPAN

TABLE 52: Japanese Market for Cancer Therapies: Annual Sales Estimates and Projections in US$ Million by Treatment Type for the Period 2018-2025

TABLE 53: Cancer Therapies Market in Japan: Historic Sales Analysis in US$ Million by Treatment Type for the Period 2009-2017

TABLE 54: Japanese Cancer Therapies Market Share Analysis by Treatment Type: 2009 VS 2019 VS 2025

TABLE 55: Japanese Market for Cancer Therapies: Annual Sales Estimates and Projections in US$ Million by Cancer Type for the Period 2018-2025

TABLE 56: Cancer Therapies Market in Japan: Historic Sales Analysis in US$ Million by Cancer Type for the Period 2009-2017

TABLE 57: Japanese Cancer Therapies Market Share Analysis by Cancer Type: 2009 VS 2019 VS 2025

CHINA

TABLE 58: Chinese Cancer Therapies Market Growth Prospects in US$ Million by Treatment Type for the Period 2018-2025

TABLE 59: Cancer Therapies Historic Market Analysis in China in US$ Million by Treatment Type: 2009-2017

TABLE 60: Chinese Cancer Therapies Market by Treatment Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 61: Chinese Cancer Therapies Market Growth Prospects in US$ Million by Cancer Type for the Period 2018-2025

TABLE 62: Cancer Therapies Historic Market Analysis in China in US$ Million by Cancer Type: 2009-2017

TABLE 63: Chinese Cancer Therapies Market by Cancer Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Cancer Therapies Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 64: European Cancer Therapies Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 65: Cancer Therapies Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 66: European Cancer Therapies Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 67: European Cancer Therapies Market Estimates and Forecasts in US$ Million by Treatment Type: 2018-2025

TABLE 68: Cancer Therapies Market in Europe in US$ Million by Treatment Type: A Historic Review for the Period 2009-2017

TABLE 69: European Cancer Therapies Market Share Breakdown by Treatment Type: 2009 VS 2019 VS 2025

TABLE 70: European Cancer Therapies Market Estimates and Forecasts in US$ Million by Cancer Type: 2018-2025

TABLE 71: Cancer Therapies Market in Europe in US$ Million by Cancer Type: A Historic Review for the Period 2009-2017

TABLE 72: European Cancer Therapies Market Share Breakdown by Cancer Type: 2009 VS 2019 VS 2025

FRANCE

TABLE 73: Cancer Therapies Market in France by Treatment Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 74: French Cancer Therapies Historic Market Scenario in US$ Million by Treatment Type: 2009-2017

TABLE 75: French Cancer Therapies Market Share Analysis by Treatment Type: 2009 VS 2019 VS 2025

TABLE 76: Cancer Therapies Market in France by Cancer Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 77: French Cancer Therapies Historic Market Scenario in US$ Million by Cancer Type: 2009-2017

TABLE 78: French Cancer Therapies Market Share Analysis by Cancer Type: 2009 VS 2019 VS 2025

GERMANY

TABLE 79: Cancer Therapies Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Treatment Type for the Period 2018-2025

TABLE 80: German Cancer Therapies Historic Market Analysis in US$ Million by Treatment Type: 2009-2017

TABLE 81: German Cancer Therapies Market Share Breakdown by Treatment Type: 2009 VS 2019 VS 2025

TABLE 82: Cancer Therapies Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Cancer Type for the Period 2018-2025

TABLE 83: German Cancer Therapies Historic Market Analysis in US$ Million by Cancer Type: 2009-2017

TABLE 84: German Cancer Therapies Market Share Breakdown by Cancer Type: 2009 VS 2019 VS 2025

ITALY

TABLE 85: Italian Cancer Therapies Market Growth Prospects in US$ Million by Treatment Type for the Period 2018-2025

TABLE 86: Cancer Therapies Historic Market Analysis in Italy in US$ Million by Treatment Type: 2009-2017

TABLE 87: Italian Cancer Therapies Market by Treatment Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 88: Italian Cancer Therapies Market Growth Prospects in US$ Million by Cancer Type for the Period 2018-2025

TABLE 89: Cancer Therapies Historic Market Analysis in Italy in US$ Million by Cancer Type: 2009-2017

TABLE 90: Italian Cancer Therapies Market by Cancer Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 91: United Kingdom Market for Cancer Therapies: Annual Sales Estimates and Projections in US$ Million by Treatment Type for the Period 2018-2025

TABLE 92: Cancer Therapies Market in the United Kingdom: Historic Sales Analysis in US$ Million by Treatment Type for the Period 2009-2017

TABLE 93: United Kingdom Cancer Therapies Market Share Analysis by Treatment Type: 2009 VS 2019 VS 2025

TABLE 94: United Kingdom Market for Cancer Therapies: Annual Sales Estimates and Projections in US$ Million by Cancer Type for the Period 2018-2025

TABLE 95: Cancer Therapies Market in the United Kingdom: Historic Sales Analysis in US$ Million by Cancer Type for the Period 2009-2017

TABLE 96: United Kingdom Cancer Therapies Market Share Analysis by Cancer Type: 2009 VS 2019 VS 2025

SPAIN

TABLE 97: Spanish Cancer Therapies Market Estimates and Forecasts in US$ Million by Treatment Type: 2018 to 2025

TABLE 98: Spanish Cancer Therapies Historic Market Review by Treatment Type in US$ Million: 2009-2017

TABLE 99: Cancer Therapies Market in Spain: Percentage Share Breakdown of Sales by Treatment Type for 2009, 2019, and 2025

TABLE 100: Spanish Cancer Therapies Market Estimates and Forecasts in US$ Million by Cancer Type: 2018 to 2025

TABLE 101: Spanish Cancer Therapies Historic Market Review by Cancer Type in US$ Million: 2009-2017

TABLE 102: Cancer Therapies Market in Spain: Percentage Share Breakdown of Sales by Cancer Type for 2009, 2019, and 2025

RUSSIA

TABLE 103: Russian Cancer Therapies Market Estimates and Projections in US$ Million by Treatment Type: 2018 to 2025

TABLE 104: Cancer Therapies Market in Russia by Treatment Type: A Historic Review in US$ Million for 2009-2017

TABLE 105: Russian Cancer Therapies Market Share Breakdown by Treatment Type: 2009 VS 2019 VS 2025

TABLE 106: Russian Cancer Therapies Market Estimates and Projections in US$ Million by Cancer Type: 2018 to 2025

TABLE 107: Cancer Therapies Market in Russia by Cancer Type: A Historic Review in US$ Million for 2009-2017

TABLE 108: Russian Cancer Therapies Market Share Breakdown by Cancer Type: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 109: Rest of Europe Cancer Therapies Market Estimates and Forecasts in US$ Million by Treatment Type: 2018-2025

TABLE 110: Cancer Therapies Market in Rest of Europe in US$ Million by Treatment Type: A Historic Review for the Period 2009-2017

TABLE 111: Rest of Europe Cancer Therapies Market Share Breakdown by Treatment Type: 2009 VS 2019 VS 2025

TABLE 112: Rest of Europe Cancer Therapies Market Estimates and Forecasts in US$ Million by Cancer Type: 2018-2025

TABLE 113: Cancer Therapies Market in Rest of Europe in US$ Million by Cancer Type: A Historic Review for the Period 2009-2017

TABLE 114: Rest of Europe Cancer Therapies Market Share Breakdown by Cancer Type: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 115: Asia-Pacific Cancer Therapies Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 116: Cancer Therapies Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017

TABLE 117: Asia-Pacific Cancer Therapies Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025

TABLE 118: Cancer Therapies Market in Asia-Pacific by Treatment Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 119: Asia-Pacific Cancer Therapies Historic Market Scenario in US$ Million by Treatment Type: 2009-2017

TABLE 120: Asia-Pacific Cancer Therapies Market Share Analysis by Treatment Type: 2009 VS 2019 VS 2025

TABLE 121: Cancer Therapies Market in Asia-Pacific by Cancer Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 122: Asia-Pacific Cancer Therapies Historic Market Scenario in US$ Million by Cancer Type: 2009-2017

TABLE 123: Asia-Pacific Cancer Therapies Market Share Analysis by Cancer Type: 2009 VS 2019 VS 2025

AUSTRALIA

TABLE 124: Cancer Therapies Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Treatment Type for the Period 2018-2025

TABLE 125: Australian Cancer Therapies Historic Market Analysis in US$ Million by Treatment Type: 2009-2017

TABLE 126: Australian Cancer Therapies Market Share Breakdown by Treatment Type: 2009 VS 2019 VS 2025

TABLE 127: Cancer Therapies Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Cancer Type for the Period 2018-2025

TABLE 128: Australian Cancer Therapies Historic Market Analysis in US$ Million by Cancer Type: 2009-2017

TABLE 129: Australian Cancer Therapies Market Share Breakdown by Cancer Type: 2009 VS 2019 VS 2025

INDIA

TABLE 130: Indian Cancer Therapies Market Estimates and Forecasts in US$ Million by Treatment Type: 2018 to 2025

TABLE 131: Indian Cancer Therapies Historic Market Review by Treatment Type in US$ Million: 2009-2017

TABLE 132: Cancer Therapies Market in India: Percentage Share Breakdown of Sales by Treatment Type for 2009, 2019, and 2025

TABLE 133: Indian Cancer Therapies Market Estimates and Forecasts in US$ Million by Cancer Type: 2018 to 2025

TABLE 134: Indian Cancer Therapies Historic Market Review by Cancer Type in US$ Million: 2009-2017

TABLE 135: Cancer Therapies Market in India: Percentage Share Breakdown of Sales by Cancer Type for 2009, 2019, and 2025

SOUTH KOREA

TABLE 136: Cancer Therapies Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Treatment Type for the Period 2018-2025

TABLE 137: South Korean Cancer Therapies Historic Market Analysis in US$ Million by Treatment Type: 2009-2017

TABLE 138: Cancer Therapies Market Share Distribution in South Korea by Treatment Type: 2009 VS 2019 VS 2025

TABLE 139: Cancer Therapies Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Cancer Type for the Period 2018-2025

TABLE 140: South Korean Cancer Therapies Historic Market Analysis in US$ Million by Cancer Type: 2009-2017

TABLE 141: Cancer Therapies Market Share Distribution in South Korea by Cancer Type: 2009 VS 2019 VS 2025

REST OF ASIA-PACIFIC

TABLE 142: Rest of Asia-Pacific Market for Cancer Therapies: Annual Sales Estimates and Projections in US$ Million by Treatment Type for the Period 2018-2025

TABLE 143: Cancer Therapies Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Treatment Type for the Period 2009-2017

TABLE 144: Rest of Asia-Pacific Cancer Therapies Market Share Analysis by Treatment Type: 2009 VS 2019 VS 2025

TABLE 145: Rest of Asia-Pacific Market for Cancer Therapies: Annual Sales Estimates and Projections in US$ Million by Cancer Type for the Period 2018-2025

TABLE 146: Cancer Therapies Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Cancer Type for the Period 2009-2017

TABLE 147: Rest of Asia-Pacific Cancer Therapies Market Share Analysis by Cancer Type: 2009 VS 2019 VS 2025

LATIN AMERICA

TABLE 148: Latin American Cancer Therapies Market Trends by Region/Country in US$ Million: 2018-2025

TABLE 149: Cancer Therapies Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017

TABLE 150: Latin American Cancer Therapies Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025

TABLE 151: Latin American Cancer Therapies Market Growth Prospects in US$ Million by Treatment Type for the Period 2018-2025

TABLE 152: Cancer Therapies Historic Market Analysis in Latin America in US$ Million by Treatment Type: 2009-2017

TABLE 153: Latin American Cancer Therapies Market by Treatment Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 154: Latin American Cancer Therapies Market Growth Prospects in US$ Million by Cancer Type for the Period 2018-2025

TABLE 155: Cancer Therapies Historic Market Analysis in Latin America in US$ Million by Cancer Type: 2009-2017

TABLE 156: Latin American Cancer Therapies Market by Cancer Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

ARGENTINA

TABLE 157: Argentinean Cancer Therapies Market Estimates and Forecasts in US$ Million by Treatment Type: 2018-2025

TABLE 158: Cancer Therapies Market in Argentina in US$ Million by Treatment Type: A Historic Review for the Period 2009-2017

TABLE 159: Argentinean Cancer Therapies Market Share Breakdown by Treatment Type: 2009 VS 2019 VS 2025

TABLE 160: Argentinean Cancer Therapies Market Estimates and Forecasts in US$ Million by Cancer Type: 2018-2025

TABLE 161: Cancer Therapies Market in Argentina in US$ Million by Cancer Type: A Historic Review for the Period 2009-2017

TABLE 162: Argentinean Cancer Therapies Market Share Breakdown by Cancer Type: 2009 VS 2019 VS 2025

BRAZIL

TABLE 163: Cancer Therapies Market in Brazil by Treatment Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 164: Brazilian Cancer Therapies Historic Market Scenario in US$ Million by Treatment Type: 2009-2017

TABLE 165: Brazilian Cancer Therapies Market Share Analysis by Treatment Type: 2009 VS 2019 VS 2025

TABLE 166: Cancer Therapies Market in Brazil by Cancer Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 167: Brazilian Cancer Therapies Historic Market Scenario in US$ Million by Cancer Type: 2009-2017

TABLE 168: Brazilian Cancer Therapies Market Share Analysis by Cancer Type: 2009 VS 2019 VS 2025

MEXICO

TABLE 169: Cancer Therapies Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Treatment Type for the Period 2018-2025

TABLE 170: Mexican Cancer Therapies Historic Market Analysis in US$ Million by Treatment Type: 2009-2017

TABLE 171: Mexican Cancer Therapies Market Share Breakdown by Treatment Type: 2009 VS 2019 VS 2025

TABLE 172: Cancer Therapies Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Cancer Type for the Period 2018-2025

TABLE 173: Mexican Cancer Therapies Historic Market Analysis in US$ Million by Cancer Type: 2009-2017

TABLE 174: Mexican Cancer Therapies Market Share Breakdown by Cancer Type: 2009 VS 2019 VS 2025

REST OF LATIN AMERICA

TABLE 175: Rest of Latin America Cancer Therapies Market Estimates and Projections in US$ Million by Treatment Type: 2018 to 2025

TABLE 176: Cancer Therapies Market in Rest of Latin America by Treatment Type: A Historic Review in US$ Million for 2009-2017

TABLE 177: Rest of Latin America Cancer Therapies Market Share Breakdown by Treatment Type: 2009 VS 2019 VS 2025

TABLE 178: Rest of Latin America Cancer Therapies Market Estimates and Projections in US$ Million by Cancer Type: 2018 to 2025

TABLE 179: Cancer Therapies Market in Rest of Latin America by Cancer Type: A Historic Review in US$ Million for 2009-2017

TABLE 180: Rest of Latin America Cancer Therapies Market Share Breakdown by Cancer Type: 2009 VS 2019 VS 2025

MIDDLE EAST

TABLE 181: The Middle East Cancer Therapies Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 182: Cancer Therapies Market in the Middle East by Region/Country in US$ Million: 2009-2017

TABLE 183: The Middle East Cancer Therapies Market Share Breakdown by Region/Country: 2009, 2019, and 2025

TABLE 184: The Middle East Cancer Therapies Market Estimates and Forecasts in US$ Million by Treatment Type: 2018 to 2025

TABLE 185: The Middle East Cancer Therapies Historic Market by Treatment Type in US$ Million: 2009-2017

TABLE 186: Cancer Therapies Market in the Middle East: Percentage Share Breakdown of Sales by Treatment Type for 2009, 2019, and 2025

TABLE 187: The Middle East Cancer Therapies Market Estimates and Forecasts in US$ Million by Cancer Type: 2018 to 2025

TABLE 188: The Middle East Cancer Therapies Historic Market by Cancer Type in US$ Million: 2009-2017

TABLE 189: Cancer Therapies Market in the Middle East: Percentage Share Breakdown of Sales by Cancer Type for 2009, 2019, and 2025

IRAN

TABLE 190: Iranian Market for Cancer Therapies: Annual Sales Estimates and Projections in US$ Million by Treatment Type for the Period 2018-2025

TABLE 191: Cancer Therapies Market in Iran: Historic Sales Analysis in US$ Million by Treatment Type for the Period 2009-2017

TABLE 192: Iranian Cancer Therapies Market Share Analysis by Treatment Type: 2009 VS 2019 VS 2025

TABLE 193: Iranian Market for Cancer Therapies: Annual Sales Estimates and Projections in US$ Million by Cancer Type for the Period 2018-2025

TABLE 194: Cancer Therapies Market in Iran: Historic Sales Analysis in US$ Million by Cancer Type for the Period 2009-2017

TABLE 195: Iranian Cancer Therapies Market Share Analysis by Cancer Type: 2009 VS 2019 VS 2025

ISRAEL

TABLE 196: Israeli Cancer Therapies Market Estimates and Forecasts in US$ Million by Treatment Type: 2018-2025

TABLE 197: Cancer Therapies Market in Israel in US$ Million by Treatment Type: A Historic Review for the Period 2009-2017

TABLE 198: Israeli Cancer Therapies Market Share Breakdown by Treatment Type: 2009 VS 2019 VS 2025

TABLE 199: Israeli Cancer Therapies Market Estimates and Forecasts in US$ Million by Cancer Type: 2018-2025

TABLE 200: Cancer Therapies Market in Israel in US$ Million by Cancer Type: A Historic Review for the Period 2009-2017

TABLE 201: Israeli Cancer Therapies Market Share Breakdown by Cancer Type: 2009 VS 2019 VS 2025

SAUDI ARABIA

TABLE 202: Saudi Arabian Cancer Therapies Market Growth Prospects in US$ Million by Treatment Type for the Period 2018-2025

TABLE 203: Cancer Therapies Historic Market Analysis in Saudi Arabia in US$ Million by Treatment Type: 2009-2017

TABLE 204: Saudi Arabian Cancer Therapies Market by Treatment Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 205: Saudi Arabian Cancer Therapies Market Growth Prospects in US$ Million by Cancer Type for the Period 2018-2025

TABLE 206: Cancer Therapies Historic Market Analysis in Saudi Arabia in US$ Million by Cancer Type: 2009-2017

TABLE 207: Saudi Arabian Cancer Therapies Market by Cancer Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED ARAB EMIRATES

TABLE 208: Cancer Therapies Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Treatment Type for the Period 2018-2025

TABLE 209: United Arab Emirates Cancer Therapies Historic Market Analysis in US$ Million by Treatment Type: 2009-2017

TABLE 210: Cancer Therapies Market Share Distribution in United Arab Emirates by Treatment Type: 2009 VS 2019 VS 2025

TABLE 211: Cancer Therapies Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Cancer Type for the Period 2018-2025

TABLE 212: United Arab Emirates Cancer Therapies Historic Market Analysis in US$ Million by Cancer Type: 2009-2017

TABLE 213: Cancer Therapies Market Share Distribution in United Arab Emirates by Cancer Type: 2009 VS 2019 VS 2025

REST OF MIDDLE EAST

TABLE 214: Cancer Therapies Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Treatment Type for the Period 2018-2025

TABLE 215: Rest of Middle East Cancer Therapies Historic Market Analysis in US$ Million by Treatment Type: 2009-2017

TABLE 216: Rest of Middle East Cancer Therapies Market Share Breakdown by Treatment Type: 2009 VS 2019 VS 2025

TABLE 217: Cancer Therapies Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Cancer Type for the Period 2018-2025

TABLE 218: Rest of Middle East Cancer Therapies Historic Market Analysis in US$ Million by Cancer Type: 2009-2017

TABLE 219: Rest of Middle East Cancer Therapies Market Share Breakdown by Cancer Type: 2009 VS 2019 VS 2025

AFRICA

TABLE 220: African Cancer Therapies Market Estimates and Projections in US$ Million by Treatment Type: 2018 to 2025

TABLE 221: Cancer Therapies Market in Africa by Treatment Type: A Historic Review in US$ Million for 2009-2017

TABLE 222: African Cancer Therapies Market Share Breakdown by Treatment Type: 2009 VS 2019 VS 2025

TABLE 223: African Cancer Therapies Market Estimates and Projections in US$ Million by Cancer Type: 2018 to 2025

TABLE 224: Cancer Therapies Market in Africa by Cancer Type: A Historic Review in US$ Million for 2009-2017

TABLE 225: African Cancer Therapies Market Share Breakdown by Cancer Type: 2009 VS 2019 VS 2025

IV. COMPETITION

AMGEN

ASTRAZENECA PLC

BAYER AG

ELI LILLY AND COMPANY

F. HOFFMANN-LA ROCHE AG

JOHNSON & JOHNSON

MERCK & CO., INC.

NOVARTIS INTERNATIONAL AG

PFIZER

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Amgen
  • Astrazeneca Plc
  • Bayer Ag
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis International Ag
  • Pfizer
Note: Product cover images may vary from those shown
Adroll
adroll